A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

Clinical Chemistry

Volumn 44, Issue 4, 1998, Pages 805-809

  Lepage, Raymond ^c   Roy, Louise ^a,c   Brossard, Jean Hugues ^a,c   Rousseau, Louise ^a,c   Dorais, Claude ^a,c   Lazure, Claude ^b   D'Amour, Pierre ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ARTICLE; BONE DISEASE; CARBOXY TERMINAL SEQUENCE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; HORMONE DETERMINATION; KIDNEY FAILURE; UREMIA;

EID: 0031901781     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.4.805     Document Type: Article

References (22)

1. Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S. Göhring U, Hitzler W. Two site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab 1988;67:353-60.
2. Togashi K, Takahashi N, Ando K, Tsukamoto Y, Marumo F. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism. Int J Artif Organs 1990;13:77-82.
3. Frolich M, Walma ST, Paulson C, Papapoulos SE. Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radioimmunoassay. Ann Clin Biochem 1990;27:69-72.
4. St. John A, Thomas MB, Davies CP, Mullan B, Dick I, Hutchison B, et al. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron 1992;61:422-7.
5. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, NozawaUng K, Ly K, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-7.
6. Ratcliffe WA, Heath DA, Ryan M, Jones SR. Performance and diagnostic applications of a two-site immunoradiometric assay for parathyrin in serum. Clin Chem 1989;35:1957-61.
7. Segre GV, D'Amour P, Hultman A, Potts JT Jr. Effects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rat. J Clin Invest 1981;67:439-48.
8. D'Amour P, Lazure C, Labelle F. Metabolism of radioiodinated carboxylterminal fragments of bovine parathyroid hormone in normal and anephric rats. Endocrinology 1985;117:127-34.
9. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, LLach F. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 1991;2:1014-20.
10. Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F. A comparison of parathyroid gland function in hemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant 1991;6: 244-51.
11. Ramirez JA, Goodman WG, Gornbein J, Menezes C, Moulton L, Segre GV, Salusky IB. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab 1993;76:1489-94.
12. Malberti F, Surian M, Cosci P. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7:822-8.
13. Messa P, Vallone C, Mioni G, Geatti O, Turrin D, Passoni N, Cruciati A. Direct in vitro assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int 1994;46: 1713-20.
14. Sanchez CP, Goodman WG, Ramirez JA, Gales B, Belin TR, Segre GV, Salusky IB. Calcium regulated parathyroid hormone secretion in adynamic renal osteodystrophy. Kidney Int 1995;48:838-43.
15. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75:145-50.
16. Colford J, Spring J, Johnson T. Data suggesting the presence of a circulating inhibitor to PTH [Abstract]. 10th Int Congress of Endocrinology. San Francisco, CA: The International Society of Endocrinology and the Endocrine Society, 1996.
17. Colford JW, Salvati M, MacFarlane G, Sokoll LJ, Levine MA. Isolation and characterization of large molecular weight fragments of PTH. [Abstract]. 79th Annual Meeting of the Endocrine Society. Minneapolis, MN: Endocrine Society, 1997.
18. Brossard JH, Whittom S, Lepage R, D'Amour P. Carboxylterminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other causes of hypercalcemia. J Clin Endocrinol Metab 1993;77:413-9.
19. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barré M, D'Amour P. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) Detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996;81:3923-9.
20. Bennet HPJ, Solomon S, Goltzman D. Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Biochem J 1981;197:391-400.
21. Segre GV, Tregear G, Potts JR Jr. Development and application of sequence-specific radioimmunoassays for analysis of the metabolism of parathyroid hormone. Methods Enzymol 1975;37:38-66.
22. Chorev M, Rosenblatt M. Structure function analysis of parathyroid hormone and parathyroid hormone-related protein. In: Bilezikiew JP, Levine MA, Marcus R, eds. The parathyroids. New York: Raven Press, 1994:139-56.